The Significance and Challenges of Monocyte Impairment: For the Ill Patient and the Surgeon

Surgical Infections

Volumn 17, Issue 3, 2016, Pages 303-312

  Galbraith, Norman ^a   Walker, Samuel ^a   Galandiuk, Susan ^a   Gardner, Sarah ^a   Polk, Hiram C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; HLA DR ANTIGEN; MICRORNA;

ANTIGEN PRESENTATION; ARTICLE; BURN; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ELECTIVE SURGERY; EX VIVO STUDY; HEMATOLOGIC DISEASE; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INJURY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR SURGERY; MEDLINE; MONOCYTE; MONOCYTE IMPAIRMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY INFECTION; SEPSIS; CROSS INFECTION; IMMUNOLOGY; MORTALITY; MULTIPLE ORGAN FAILURE; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK ASSESSMENT; SURGICAL WOUND INFECTION;

CROSS INFECTION; HUMANS; MONOCYTES; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK ASSESSMENT; SURGICAL WOUND INFECTION;

EID: 84971222256     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2015.245     Document Type: Article

References (66)

1. Trunkey DD. Trauma. Accidental and intentional injuries account for more years of life lost in the U.S. than cancer and heart disease. Among the prescribed remedies are improved preventive efforts, speedier surgery and further research. Sci Am 1983;249:28-35.
2. Fry DE, Pearlstein L, Fulton RL, et al. Multiple system organ failure. The role of uncontrolled infection. Arch Surg 1980;115:136-140.
3. Faist E, Baue AE, Dittmer H, et al. Multiple organ failure in polytrauma patients. J Trauma 1983;23:775-787.
4. Demetriades D, Kimbrell B, Salim A, et al. Trauma deaths in a mature urban trauma system: Is ''trimodal'' distribution a valid concept? J Am Coll Surg 2005;201:343-348.
5. Polk HC, Jr., George CD, Wellhausen SR, et al. A systematic study of host defense processes in badly injured patients. Ann Surg 1986;204:282-299.
6. Hershman MJ, Cheadle WG, Wellhausen SR, et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990;77:204-207.
7. Polk HC, Jr., Lamont PM, Galland RB. Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection. Infect Immun 1990;58:1807-1811.
8. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010;116:e74-e80.
9. Ziegler-Heitbrock L, Hofer TP. Toward a refined definition of monocyte subsets. Front Immunol 2013;4:23.
10. Faist E, Kupper TS, Baker CC, et al. Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg 1986;121:1000-1005.
11. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32:1175-1183.
12. Venet F, Tissot S, Debard AL, et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med 2007;35:1910-1917.
13. Lahiri R, Derwa Y, Bashir Z, et al. Systemic inflammatory response syndrome after major abdominal surgery predicted by early upregulation of TLR4 and TLR5. Ann Surg 2015. Epub ahead of print; PubMed PMID:26020106.
14. CheadleWG, HershmanMJ,Wellhausen SR, et al. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 1991;161:639-645.
15. Ploder M, Pelinka L, Schmuckenschlager C, et al. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 2006;25:129-134.
16. Lin ZQ, Guo J, Xia Q, et al. Human leukocyte antigen-DR expression on peripheral monocytes may be an early marker for secondary infection in severe acute pancreatitis. Hepatogastroenterology 2013;60:1896-1902.
17. Gaudilliere B, Fragiadakis GK, Bruggner RV, et al. Clinical recovery from surgery correlates with single-cell immune signatures. Sci Transl Med 2014;6:255ra131.
18. Longbottom ER, Torrance HD, Owen HC, et al. Features of postoperative immune suppression are reversible with interferon gamma and independent of interleukin-6 Pathways. Ann Surg 2015. Epub ahead of print; PubMed PMID: 26445474.
19. Lyons A, Kelly JL, Rodrick ML, et al. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997;226:450-458.
20. Stensballe J, Christiansen M, Tonnesen E, et al. The early IL-6 and IL-10 response in trauma is correlated with injury severity and mortality. Acta Anaesthesiol Scand 2009;53: 515-521.
21. Hoffman JA, Weinberg KI, Azen CG, et al. Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients. Transpl Infect Dis 2004;6:147-155.
22. Handy JM, Scott AJ, Cross AM, et al. HLA-DR expression and differential trafficking ofmonocyte subsets following low to intermediate risk surgery. Anaesthesia 2010;65:27-35.
23. Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996;224:647-664.
24. Gouel-Cheron A, Allaouchiche B, Guignant C, et al. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: A powerful association to predict the development of sepsis after major trauma. PLoS One 2012;7:e33095.
25. Guignant C, Lepape A, Huang X, et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 2011;15:R99.
26. Hietbrink F, Koenderman L, van Wessem KJ, et al. The impact of intramedullary nailing of tibia fractures on the innate immune system. Shock 2015;44:209-214.
27. Kirchhoff C, Biberthaler P, Mutschler WE, et al. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: A cohort study. Crit Care 2009; 13:R88.
28. Sfeir T, Saha DC, Astiz M, et al. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 2001;29:129-133.
29. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011;208:2581-2590.
30. Laudanski K, Miller-Graziano C, Xiao W, et al. Cellspecific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc Natl Acad Sci U S A 2006;103:15564-15569.
31. Thompson CM, Park CH, Maier RV, et al. Traumatic injury, early gene expression, and gram-negative bacteremia. Crit Care Med 2014;42:1397-1405.
32. Namas RA, Vodovotz Y, Almahmoud K, et al. Temporal patterns of circulating inflammation biomarker networks differentiate susceptibility to nosocomial infection following blunt trauma in humans. Ann Surg 2016;263:191-198.
33. Almahmoud K, Namas RA, Abdul-Malak O, et al. Impact of injury severity on dynamic inflammation networks following blunt trauma. Shock 2015;44:101-109.
34. Asadullah K, Woiciechowsky C, Docke WD, et al. Very low monocytic HLA-DR expression indicates high risk of infection-immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med 1995;2:184-190.
35. Van den Berk JM, Oldenburger RH, van den Berg AP, et al. Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation 1997;63:1846-1848.
36. Oczenski W, Krenn H, Jilch R, et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 2003;29:1253-1257.
37. Albertsmeier M, Quaiser D, von Dossow-Hanfstingl V, et al. Major surgical trauma differentially affects T-cells and APC. Innate Immun 2015;21:55-64.
38. Cajander S, Backman A, Tina E, et al. Preliminary results in quantitation of HLA-DRA by real-time PCR: A promising approach to identify immunosuppression in sepsis. Crit Care 2013;17:R223.
39. Turrel-Davin F, Venet F, Monnin C, et al. mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance. Crit Care 2011; 15:R252.
40. Allantaz-Frager F, Turrel-Davin F, Venet F, et al. Identification of biomarkers of response to IFNg during endotoxin tolerance: Application to septic shock. PLoS One 2013;8:e68218.
41. Fontaine M, Planel S, Peronnet E, et al. S100A8/A9 mRNA induction in an ex vivo model of endotoxin tolerance: Roles of IL-10 and IFNgamma. PLoS One 2014;9:e100909.
42. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13:260-268.
43. Zhang Y, Zhou Y, Lou J, et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care 2010;14:R220.
44. Zhu W, Bao R, Fan X, et al. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model. Mediators Inflamm 2013;2013:361501.
45. Monaghan SF, Thakkar RK, Tran ML, et al. Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient. Shock 2012;38:117-122.
46. Mansur A, Hinz J, Hillebrecht B, et al. Ninety-day survival rate of patients with sepsis relates to programmed cell death 1 genetic polymorphism rs11568821. J Investig Med 2014; 62:638-643.
47. Billeter AT, Hellmann J, Roberts H, et al. MicroRNA-155 potentiates the inflammatory response in hypothermia by suppressing IL-10 production. FASEBJ 2014;28:5322-5336.
48. QadanM,Weller EB, Gardner SA, et al. Glucose and surgical sepsis:Astudy of underlying immunologicmechanisms. JAm Coll Surg 2010;210:966-974.
49. Qadan M, Battista C, Gardner SA, et al. Oxygen and surgical site infection: A study of underlying immunologic mechanisms. Anesthesiology 2010;113:369-377.
50. Muszynski JA, Frazier E, Nofziger R, et al. Red blood cell transfusion and immune function in critically ill children: A prospective observational study. Transfusion 2014.
51. Muszynski JA, Bale J, Nateri J, et al. Supernatants from stored red blood cell (RBC) units, but not RBC-derived microvesicles, suppress monocyte function in vitro. Transfusion 2015;55:1937-1945.
52. Veenhof AA, Sietses C, von Blomberg BM, et al. The surgical stress response and postoperative immune function after laparoscopic or conventional total mesorectal excision in rectal cancer: A randomized trial. Int J Colorectal Dis 2011;26:53-59.
53. Shibata J, Ishihara S, Tada N, et al. Surgical stress response after colorectal resection: A comparison of robotic, laparoscopic, and open surgery. Tech Coloproctol 2015;19: 275-280.
54. Chopra SS, Haacke N, Meisel C, et al. Postoperative immunosuppression after open and laparoscopic liver resection: Assessment of cellular immune function and monocytic HLA-DR expression. JSLS 2013;17:615-621.
55. Sista F, Schietroma M, Santis GD, et al. Systemic inflammation and immune response after laparotomy vs laparoscopy in patients with acute cholecystitis, complicated by peritonitis. World J Gastrointest Surg 2013;5:73-82.
56. Veenhof AA, Vlug MS, van der Pas MH, et al. Surgical stress response and postoperative immune function after laparoscopy or open surgery with fast track or standard perioperative care: A randomized trial. Ann Surg 2012;255: 216-221.
57. Fujita T. Interpreting postoperative CRP response and HLA-DR depression. Ann Surg 2015;261:e39.
58. Beeson PB, Technical Assistance of Elizabeth R. Tolerance to Bacterial Pyrogens: I. Factors Influencing Its Development. J Exp Med 1947;86:29-38.
59. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006;10:233.
60. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends Immunol 2009;30:475-487.
61. Draisma A, Pickkers P, Bouw MP, et al. Development of endotoxin tolerance in humans in vivo. Crit Care Med 2009;37:1261-1267.
62. Wolk K, Docke WD, von Baehr V, et al. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000;96:218-223.
63. Del Fresno C, Garcia-Rio F, Gomez-Pina V, et a. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: Demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009;182:6494-6507.
64. Murphy M, Xiong Y, Pattabiraman G, et al. Pellino-1 positively regulates toll-like receptor (TLR) 2 and TLR4 signaling and is suppressed upon induction of endotoxin tolerance. J Biol Chem 2015;290:19218-19232.
65. Xiong Y, Qiu F, Piao W, et al. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-betaactivated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression. J Biol Chem 2011;286:7905-7916.
66. Ziegler-Heitbrock L. The p50-homodimer mechanism in tolerance to LPS. J Endotoxin Res 2001;7:219-222.